Non-specific effect of vaccines: Immediate protection against respiratory syncytial virus infection by a live attenuated influenza vaccine

Young J. Lee, Jeong Y. Lee, Yo H. Jang, Sang Uk Seo, Jun Chang, Baik L. Seong

Research output: Contribution to journalArticlepeer-review

53 Scopus citations

Abstract

The non-specific effects (NSEs) of vaccines have been discussed for their potential long-term beneficial effects beyond direct protection against a specific pathogen. Cold-adapted, live attenuated influenza vaccine (CAIV) induces local innate immune responses that provide a broad range of antiviral immunity. Herein, we examined whether X-31ca, a donor virus for CAIVs, provides non-specific cross-protection against respiratory syncytial virus (RSV). The degree of RSV replication was significantly reduced when X-31ca was administered before RSV infection without any RSV-specific antibody responses. The vaccination induced an immediate release of cytokines and infiltration of leukocytes into the respiratory tract, moderating the immune perturbation caused by RSV infection. The potency of protection against RSV challenge was significantly reduced in TLR3-/- TLR7-/- mice, confirming that the TLR3/7 signaling pathways are necessary for the observed immediate and short-term protection. The results suggest that CAIVs provide short-term, non-specific protection against genetically unrelated respiratory pathogens. The additional benefits of CAIVs in mitigating acute respiratory infections for which vaccines are not yet available need to be assessed in future studies.

Original languageEnglish
Article number83
JournalFrontiers in Microbiology
Volume9
Issue numberJAN
DOIs
StatePublished - 31 Jan 2018

Bibliographical note

Publisher Copyright:
© 2018 Lee, Lee, Jang, Seo, Chang and Seong.

Keywords

  • Cold-adapted live attenuated influenza vaccine
  • Cross-protection
  • Innate immunity
  • Non-specific effects
  • RSV
  • Toll-like receptor

Fingerprint

Dive into the research topics of 'Non-specific effect of vaccines: Immediate protection against respiratory syncytial virus infection by a live attenuated influenza vaccine'. Together they form a unique fingerprint.

Cite this